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Abstract
Background: Our purpose was to evaluate the impact of lifestyle behavior modification on glycemic control
among children and youth with clinically defined Type 2 Diabetes (T2D).
Methods: We conducted a systematic review of studies (randomized trials, quasi-experimental studies) evaluating
lifestyle (diet and/or physical activity) modification and glycemic control (HbA1c). Our data sources included
bibliographic databases (EMBASE, CINAHL®, Cochrane Library, Medline®, PASCAL, PsycINFO®, and Sociological
Abstracts), manual reference search, and contact with study authors. Two reviewers independently selected studies
that included any intervention targeting diet and/or physical activity alone or in combination as a means to reduce
HbA1c in children and youth under the age of 18 with T2D.
Results: Our search strategy generated 4,572 citations. The majority of citations were not relevant to the study
objective. One study met inclusion criteria. In this retrospective study, morbidly obese youth with T2D were treated
with a very low carbohydrate diet. This single study received a quality index score of < 11, indicating poor study
quality and thus limiting confidence in the study’s conclusions.
Conclusions: There is no high quality evidence to suggest lifestyle modification improves either short- or long-
term glycemic control in children and youth with T2D. Additional research is clearly warranted to define optimal
lifestyle behaviour strategies for young people with T2D.
Background
Globally, the prevalence of Type 2 Diabetes (T2D) in the
pediatric population is increasing, most notably among
15 - 18 year olds [1-4]. At diagnosis, most boys and
girls with T2D are overweight or obese, have a positive
family history of T2D, are peri- or post-pubertal, and
present with metabolic risk factors (e.g., dyslipidemia)
[5]. With the early onset of this chronic condition and
the associated co-morbidities, a life-long reduction in
quality of life and premature mortality due to micro-
and macro-vascular complications can be expected [6].
To address this health challenge resulting from pediatric
T2D, effective and efficient management strategies are
necessary.
Strong evidence supports the role of lifestyle modifica-
tion to prevent (or at least delay) T2D in adults [7-11].
On this basis, many current clinical practice guidelines
for adults with T2D recommend lifestyle modifications
that include improving dietary quality as well as increas-
ing the quantity and quality of physical activity to pro-
mote weight management and improve glycemic control
[12-14]. Current treatment guidelines for children and
y o u t hw i t hT 2 Dd on o td i f f e r from adult recommenda-
tions. Among children and youth who are asymptomatic
(i.e., free of polyuria, polydipsia, or ketoacidosis) at diag-
nosis, intensive lifestyle counseling is recommended to
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fasting plasma glucose < 6.6 mmol/L) within 3 to
6 months [13-17]. If this clinical target is not achieved,
initiation of metformin, an oral hypoglycemic agent, is
recommended; in some cases, insulin therapy may also
be necessary [16,18].
Although there is little data currently available on
treatment patterns for children with T2D, it appears
most boys and girls with T2D are treated pharmacologi-
cally [12]. It is not known whether this is a reflection of
poor adherence to lifestyle modifications in children and
youth or because clinicians’ perceptions of and experi-
ences with lifestyle recommendations and interventions
are less effective for managing T2D in this population.
To address this knowledge gap, we conducted a sys-
tematic review to evaluate the impact of lifestyle beha-
vior modification on glycemic control among children
and youth with clinically defined T2D.
Methods
Literature Search Strategy
A research librarian, with input from the research team,
developed and implemented a comprehensive search
strategy in selected high-yield electronic databases
(EMBASE, CINAHL®, Cochrane Library, Medline®, PAS-
CAL, PsycINFO®, and Sociological Abstracts) from their
date of inception until October 2007. An updated search
was completed in May 2009 (See Additional file1 for
search terms). Relevant articles were also sought by
searching the reference lists from articles retrieved for
detailed review as well as related review articles pub-
lished from January 2002 onward. Personal contact was
established with content experts and authors of selected
review articles to ensure relevant publications were not
missed. No language restrictions were applied in this
search strategy.
Study Inclusion and Selection Criteria
We included all studies designed to evaluate the impact
of lifestyle modification (diet and/or physical activity) on
glycemic control (HbA1c) in children or youth with
T2D. Lifestyle modification and glycemic control among
children and youth with impaired glucose tolerance or
impaired fasting glucose were not included. Similarly,
the use of anti-diabetic drug therapies was not formally
assessed. However, if a lifestyle modification group was
included in any study design, the data were considered
for inclusion. Studies were excluded if they did not
include a comparison group or were not relevant to
children and youth.
Two reviewers (STJ and MC) independently reviewed
all abstracts and references. Studies were included if
they met the following criteria: original research, partici-
pants ≤18 years of age with T2D, evaluated the effect of
lifestyle modification (diet and/or physical activity) on
glycemic control (HbA1c). Inter-observer agreement for
study inclusion was high ( = 0.92). Once the initial
review was complete, a third investigator (GDCB)
resolved any discrepancies by consensus.
Quality Assessment
Assessment of the methodologic quality of included stu-
dies was completed using criteria from Downs and
Black [19], which assessed study characteristics includ-
ing internal and external validity, power, and reporting.
A maximal quality index (QI) score was given to
selected studies. A QI score >20 rated good,1 1t o2 0
rated moderate and <11 rated poor [19]. Two reviewers
(STJ and MC) independently completed quality assess-
ments of included studies. Any discrepancies were
resolved through third party discussion (GDCB).
Results
Figure 1 shows the selection process for this systematic
review. From the 4,572 publications identified by review-
ing titles and abstracts, 61 manuscripts were selected for
complete review. Of these manuscripts, 19 review articles
were identified and removed. Additionally, seven cohort
studies [20-26] and one case-study [27] were identified
and reviewed because they were closely related to our
research question, but did not fully match our inclusion
criteria (Table 1). The cohort studies mainly described
treatment trajectories, behavioral characteristics, disease
management strategies, or quality of life among children
and youth with T2D; however, they lacked a defined life-
style intervention or comparator group. Although the
identified case-study included a specific lifestyle interven-
tion for one child with T2D, it was excluded based on the
nature of the study design. One other study [28]
described the evaluation of a community-based program
that focused on food preparation skills, but did not
include behavioral or clinical outcomes (Table 1). No
additional studies were identified through our examina-
tion of study reference lists. Contact with experts in the
field of pediatric T2D yielded two additional manuscripts,
but upon review, these studies did not satisfy our inclu-
sion criteria. In the end, one study (a retrospective, case-
control design) met our inclusion criteria [29].
In the study by Willi et al., [29], the use of a very low
carbohydrate diet in the treatment of T2D was found be
an effective short-term therapy. However, this study was
of poor methodological quality and its results should be
interpreted with caution. The results are at high risk for
bias because it was a convenience sample of hospital-
based patients and was not a prospective design with
random assignment to treatment and control. This
study received a QI score of <11 (rated poor); additional
details of this report are described in Table 2.
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Current treatment guidelines state that children and
youth with T2D should receive intensive lifestyle coun-
seling to help them achieve target glycemia within 3 - 6
months following diagnosis [12-16]. Despite this recom-
mendation, our review of the literature revealed only
one study that targeted lifestyle modification (diet) as an
approach for improving glycemic control in this popula-
tion. To date, most published studies have either
included adults exclusively or have been based on retro-
spective or cross-sectional cohort studies of boys and
girls with insulin resistance, but without T2D. Our
Potentially eligible studies screened 
through electronic databases 
(n=4572)
Studies excluded: irrelevant to research 
question or inappropriate study designs 
(n=4404)
Potentially eligible abstracts screened 
(n=168)
Studies excluded: irrelevant to research 
questions or inappropriate study designs 
(n=107)
Detailed review of manuscripts
(n=61)
Reference lists from published review 
articles relevant to research question 
screened and the review articles were 
removed.
(n=19)
Potentially eligible studies identified 
through contact with authors/content 
experts 
(n=2)
Studies included for quality assessment
(n=1)
Studies excluded: irrelevant to research 
questions or inappropriate study designs 
(n=43)
Figure 1 Flow diagram of systematic search.
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question regarding lifestyle intervention effects on HbA1c in children or youth with type 2 diabetes (T2D)
Study
Authors
Primary Objective(s) Research Methods Intervention-Related Findings Study Limitations
Zdravkovic et
al., 2004 [20]
To review the clinical
experience of children and
teens diagnosed with T2D at a
pediatric hospital serving a
large urban multi-ethnic
population
Retrospective medical chart
review (n = 41)
54% of patients were initially
treated by lifestyle (diet and
exercise); the minority (3%) did
not require short-term
intensification (i.e., medication)
of therapy at some point since
initial diagnosis to help achieve
glycemia goals
Low quality study design;
variable intervention elements
(i.e., modality, duration,
intensity); inconsistent outcome
evaluation
Grinstein et al.,
2003 [21]
To report the presentation and
5-year treatment requirements
of African-American and
Caribbean-Hispanic adolescents
with T2D followed at the
Montefiore Medical Centre
(Bronx, NY, USA)
Retrospective medical chart
review (n = 83)
Most patients (63%) were
prescribed oral medication
(glipizide and/or metformin)
and/or insulin. All patients were
referred to a nutritionist for
dietary counselling and
recommendation of
appropriate exercise
intervention
Low quality study design;
undefined lifestyle intervention
elements (i.e., modality,
duration, intensity);
undocumented independent
effects of lifestyle variables on
glycemia
Zuhri-Yafi et
al., 2002 [22]
To study possible treatment
modalities for type 2 diabetes
in children and adolescents.
Retrospective medical chart
review (n = 25); insulin the
only initial treatment in 72% (n
= 18); weight management
strategies were taught and
encouraged; insulin was
withdrawn as euglycemia was
achieved.
Mean change in HbA1c over
2 years: -2.9% for insulin users
only and -2.3% for those
treated with insulin and
metformin, and -4.4.% for those
treated by metformin alone.
Few patents sustained any
weight loss regardless of
treatment.
Low quality study design; no
description of diet and physical
activity elements; inconsistent
results with low statistical
power to detect intervention
effects.
Rothman et
al., 2008 [23]
To examine self-management
behaviours and glycemic
control among adolescents
with T2D
Telephone survey +
retrospective medical chart
review (n = 103)
Minority (11.8%) used lifestyle
changes exclusively as
treatment. More than 80% of
patients reported ≥75%
medication compliance. More
than 70% of patients reported
exercising ≥2×/week; 68%
reported viewing ≥2 hours of
television daily. Patients
reported frequent episodes of
overeating, drinking sugar-
sweetened beverages, and
eating fast food. Many (37%)
reported that ‘following diet or
exercise regime’ was the
‘hardest thing about having
diabetes’
Data derived from cross-
sectional, self-report survey and
chart abstraction; non-specific
intervention details queried
Reinehr et al.,
2008 [24]
To study the 2-year course of
children and adolescents with
T2D in general practice to
present (1) the treatment
modalities, (2) patient
adherence, and (3) the
occurrence of comorbidities.
Clinical data collected
prospectively from 1995 to
2003 among 129 children and
adolescents with type 2
diabetes from 62 specialized
diabetes centers in Germany
Reduction in median HbA1c
after 2 years; 60% of children
dropped out of the study.
Lifestyle intervention as sole
treatment was usually not
useful for achieving long-term
metabolic control.
High number of cases lost to
follow-up; poorly defined
lifestyle intervention elements.
Shield et al.,
2009 [25]
To report the 1-year outcome
for children newly diagnosed
as having T2D across the UK.
Retrospective medical chart
review (n = 73); follow-up
occurred one year after
incident cases were ascertained
Most common treatment at
diagnosis was metformin
(n = 34; 47%); lifestyle (diet and
physical activity) was the initial
treatment for a sub-group
(n = 12; 17%); necessary
lifestyle changes needed to
positively affect metabolic
health are not occurring;
heterogeneity of treatment
regimens appears relatively
effective in achieving glycemic
control.
Low quality study; inadequate
detail regarding lifestyle
intervention elements; no
direct report of lifestyle
behaviours.
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question regarding lifestyle intervention effects on HbA1c in children or youth with type 2 diabetes (T2D) (Continued)
Allan et al.,
2008 [26]
(1) To assess quality of life
(QOL) in youth with type 2
diabetes, (2) to compare youth
and parent-proxy perceptions
of youth QOL, (3) to determine
if youth QOL is associated with
diabetes control, and (4) to
determine if demographic and/
or medical history is associated
with youth QOL and/or
diabetes control.
Cross-sectional survey and
clinical data collection among
First Nation youth aged 7-18
years and their parents at a
regional diabetes program; 39%
received lifestyle counselling
alone with remainder receiving
either insulin monotherapy or
combination with oral
hypoglycmeic agent; mean
HbA1c 9.2 ± 2.9%
Youth reported higher scores in
the generic and diabetes
related domains compared to
parents. Youth not taking
diabetes medications reported
higher QOL. QOL may be
affected by specific
demographic and clinical
factors to reduce the
psychosocial burden of their
disease.
Low quality study; inadequate
detail regarding lifestyle
intervention elements.
Anderson &
Dean (1990)
[27]
To investigate the effect of a
regulated food intake and daily
exercise program on blood
glucose levels, total
glycosylated hemoglobin and
weight status over a 3-year
period.
Case study (n = 1); subject
attended a month-long
summer camp for three
successive years.
Average HbA1c over 29
months was 18.4% with the
lowest value of 16.9% occurring
after summer camp. Controlled
food intake and daily exercise
improves glycemic control and
in controlled environment only.
Low quality study design; small
sample size limits
generalizability; Glycemic target
difficult to reach with intensive
lifestyle intervention.
Nichol et al.,
2008 [28]
(1) To modify the Canadian
Diabetes Association Pacific
Area’s Cooking For Your Life!
Program for youth with T2D
(or impaired glucose tolerance)
and their families; (2) to
evaluate program satisfaction
Pilot study (n = 15 adolescents;
n = 21 family members);
intervention included three
‘hands-on’ cooking classes +
one grocery store tour
Three out of four sessions were
attended by 86% of
participants; 90% were ‘mostly
satisfied’ or ‘completely
satisfied’ with the program
Low quality study design; study
not designed to impact
glycemic control; study
focussed on feasibility and
process-related outcomes
HgbA1c - glycated hemoglobin; QOL - quality of life; T2D - type 2 diabetes.
Table 2 Methods, design, and quality of studies for diet and physical activity in the treatment of pediatric type 2
diabetes mellitus
Study
Authors
Primary Objective(s) Methods Results Authors’ Conclusions
Willi et al.,
2004 (29)
To examine “the use of a
ketogenic, very-low-
calorie diet (VLCD) in the
treatment of type 2
diabetes”
Retrospective case-control
study, in a sample of 20
morbidly obese (body mass
index (BMI) > 30 kg/m
2)
youth (14.5 ± 0.4 years old)
with T2D. A control group
(n = 15), matched by age,
race, gender, BMI, T2D
duration, HbA1c and
pharmacotherapy who
attended a hospital-based,
outpatient pediatric diabetes
clinic were included.
Participants who adhered to the
VLCD for > 6 weeks (n = 15), had a
16% reduction in HbA1c (8.8 ± 0.6 to
7.4 ± 0.6, p < 0.005) after 8 weeks;
adherence (total days) was
associated with a greater reduction
in HbA1c (r = -0.57, p < 0.01). In this
same group, a reduction in BMI (43.5
± 1.8 kg/m
2 to 39.3 ± 1.7 kg/m
2,p<
0.0001) was observed after 8 weeks.
At two years follow-up, glycemic
control had returned to baseline in
the VLCD group. Among those who
consumed the VLCD diet for > 6
weeks (number not specified), BMI
was significantly lower compared to
baseline values within the treatment
vs. control group (absolute HgbA1c
values and statistical comparison
data not provided). A sustained
improvement in BMI in the VLCD
group at 2 years follow-up compared
to baseline assessment (41.2 ± 2.1 vs.
44.2 ± 2.3 vs. 41.2 ±21. kg/m
2,p<
0.05) and compared to the control
group, who had a 3.7% increase in
BMI from baseline.
“The ketogenic VLCD is an effective
short-term, and possibly long-term,
therapy for pediatric patients with
type 2 diabetes”. (QI score = 8 or
poor)
†
† Quality index based on Downs and Black (19) for the assessment of the methodological quality of randomized and nonrandomized studies of health
interventions;
VLCD - Very Low Carbohydrate Diet; BMI - Body Mass Index; HgbA1c - glycated hemoglobin; kcal - kilocalories.
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included physical activity interventions to improve
short- or long-term glycemic control in children and
youth with T2D, nor did it uncover any studies that
examined the influence of combining diet and physical
activity in the treatment of pediatric T2D. While we
identified many review articles concerning the manage-
ment of T2D in this population, none offered new data
regarding the efficacy or effectiveness of lifestyle man-
agement for glycemic control.
The lack of published studies of lifestyle management
for pediatric T2D may reflect the relatively low preva-
lence of the disease. Despite some having described
pediatric diabetes to be at ‘epidemic levels’ [30-32],
others argue prevalence estimates are of modest con-
cern, even among those populations believed to be at
greater risk [33]. Nevertheless, current prevalence esti-
mates of overweight and obesity are cause for concern
with respect to the potential for developing T2D and
suggest a need for evidence-based recommendations for
those who have already been diagnosed and those at
high risk.
The Diabetes Prevention Program [7] and other life-
style interventions for adults at high risk for T2D [8,9]
have provided a model for clinicians and researchers
upon which to base the design, delivery, and evaluation
of clinical trials for T2D management. Indeed, these stu-
dies have informed the design of a recently-launched
T2D management trial, which includes a lifestyle com-
ponent [34]. However, it is important to bear in mind
that pediatric and adult populations rarely receive simi-
lar therapies in research or clinical settings due to dis-
tinct metabolic, physical, developmental, and cognitive
differences. Moreover, within the context of pediatric
behavior modification, consideration of the complex
interrelationships between environmental factors (i.e.,
family, peers, school, media, built environment) must be
taken into account. Therefore, caution must be exer-
cised when generalizing the clinical findings from cur-
rently available adult data to the pediatric population.
Of additional importance is the selection of appropri-
ate study outcomes among the pediatric population [35].
Although good glycemic control and healthy body
weights are of clinical importance, the antecedents of
these clinical outcomes may be more salient [36]. For
example, parental interactions with their sons and
daughters when making family lifestyle changes have a
meaningful impact [37] to the extent that the style with
which parents communicate with and set boundaries
within their family has considerable influence on chil-
dren’s nutrition and physical activity behaviours [38]. In
this regard, evaluating outcomes such as parenting style,
self-efficacy, and motivation to change lifestyle beha-
viours can help to contextualize nutrition and physical
activity behaviours as well as metabolic outcomes that
are influenced by lifestyle. Moreover, the current
evidence-base for weight management may not be a sui-
table proxy for programs for pediatric T2D since many
of the contemporary studies of pediatric weight manage-
ment have been carried out on pre-adolescent children
from primarily Caucasian, middle socioeconomic
families. The current cohort of pediatric T2D patients
includes (primarily) less affluent families of minority
ethnic/racial backgrounds as well as families living with
generations of chronic disease and co-morbidities of dia-
betes for which the disparities in health outcomes are
well known in the adult T2D population.
Children and youth with T2D are usually overweight
or obese [17]. Current pediatric and adult literature pro-
vides good evidence for reducing energy intake and
increasing energy expenditure to enable weight manage-
ment and reduce the risk of T2D. In adults, however,
weight loss is not always necessary to improve glycemic
control [39]. Until more evidence is available, it remains
unknown whether glycemia can be improved in children
and youth with T2D independent of weight loss. How-
ever, factors that can impact the achievement and sus-
tainability of healthy lifestyle changes are increasingly
being characterized. For example, a comprehensive
health assessment prior to intervention enrolment
would enable the design of interventions that are tai-
lored to the needs of individuals and families, an
advancement that can optimize outcomes in sub-groups
with similar features. Weight management interventions
that customize treatment based on loss of control eating
[40], melanocortin 4 receptor gene mutation [41],
maternal mental health [42], and/or motivation [43]
could maximize individual responsiveness to weight
management therapies. This degree of sophistication
represents a substantial improvement beyond traditional
variables (i.e., age, gender, obesity status) that, to date,
have determined study inclusion and intervention
approaches. This would also p r o v i d ead e g r e eo fi n t e r -
vention sophistication that moves beyond a ‘one size fits
all’ for managing T2D.
Presently, the U.S. National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) is supporting a
number of large-scale, multi-centre trials designed to
prevent or treat T2D in children and youth under the
collaborative titled Studies to Treat Or Prevent Pediatric
Type 2 Diabetes (STOPP-T2D). This partnership focuses
on treating adolescents already diagnosed with T2D [34]
and on the primary prevention of T2D among middle-
school aged youth [44]. Unfortunately, following the
completion of the NIDDK sponsored trial (Treatment
Options for type 2 Diabetes in Adolescents and Youth:
TODAY) [34], the independent effects of the dietary
and physical activity behavioural changes on glycemic
Johnson et al. BMC Pediatrics 2010, 10:97
http://www.biomedcentral.com/1471-2431/10/97
Page 6 of 8control will remain unknown; the trial does not include
an independent lifestyle modification arm. Nevertheless,
trials such as these are urgently needed to inform clini-
cal practice.
The strengths of this study include the systematic,
comprehensive and unbiased approach. The results of
our systematic review should however be viewed in light
of several limitations. An intrinsic limitation of any sys-
tematic review is the potential for publication and selec-
tion bias. We acknowledge this methodological
drawback and undertook manual searches and contacted
recognized experts in pediatric endocrinology. This
strategy did not yield any additional unpublished articles
that satisfied our inclusion criteria, so it is unlikely that
we missed any relevant articles.
Conclusion
In summary, our systematic review indicated that no
well-designed studies have evaluated the impact of life-
style modification on glycemic control in children and
youth with T2D. Numerous review articles have been
published in this area, but contribute little to our evi-
dence base. Randomized clinical trials must be per-
formed to clearly establish the role of nutrition and
physical activity interventions in managing pediatric
T2D. These studies might also help to determine the
optimal lifestyle treatment approaches for good glycemic
control independent of pharmacologic therapy for the
pediatric T2D population. We believe that research to
examine lifestyle-based therapies, which consider both
qualitative and quantitative aspects of nutrition and phy-
sical activity in boys and girls with T2D, should remain
research and public health priorities.
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